Interferons as anticancer agents.
D000230:Adenocarcinoma / Q000628:therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000628:therapy; D007951:Leukemia, Myeloid / Q000628:therapy; D051379:Mice; D012330:RNA, Double-Stranded / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000628:therapy
D000970:Antineoplastic Agents; D007370:Interferon Type I; D012330:RNA, Double-Stranded; D007371:Interferon-gamma; D007372:Interferons